Literature DB >> 11883647

Thermophysical properties of pharmaceutically compatible buffers at sub-zero temperatures: implications for freeze-drying.

Evgenyi Y Shalaev1, Tiffany D Johnson-Elton, Liuquan Chang, Michael J Pikal.   

Abstract

PURPOSE: To evaluate crystallization behavior and collapse temperature (Tg') of buffers in the frozen state, in view of its importance in the development of lyophilized formulations.
METHODS: Sodium tartrate, sodium malate, potassium citrate, and sodium citrate buffers were prepared with a pH range within their individual buffering capacities. Crystallization and the Tg' were detected during heating of the frozen solutions using standard DSC and modulated DSC.
RESULTS: Citrate and malate did not exhibit crystallization, while succinate and tartrate crystallized during heating of the frozen solutions. The citrate buffer had a higher Tg' than malate and tartrate buffers at the same pH. Tg' vs. pH graphs for citrate and malate buffers studied had a similar shape, with a maximum in Tg' at pH ranging from 3 to 4. The Tg' maximum was explained as a result of a competition between two opposing trends: an increase in the viscosity of the amorphous phase because of an increase in electrostatic interaction, and a decrease in the Tg' because of an increase in a water concentration of the freeze-concentrated solution.
CONCLUSION: Citrate buffer was identified as the preferred buffer for lyophilized pharmaceuticals because of its higher Tg' and a lower crystallization tendency.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11883647     DOI: 10.1023/a:1014229001433

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Properties of citric acid at the glass transition.

Authors:  Q Lu; G Zografi
Journal:  J Pharm Sci       Date:  1997-12       Impact factor: 3.534

Review 2.  Rational design of stable lyophilized protein formulations: some practical advice.

Authors:  J F Carpenter; M J Pikal; B S Chang; T W Randolph
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

3.  Physical state of L-histidine after freeze-drying and long-term storage.

Authors:  T Osterberg; T Wadsten
Journal:  Eur J Pharm Sci       Date:  1999-08       Impact factor: 4.384

4.  Salt precipitation during the freeze-concentration of phosphate buffer solutions.

Authors:  N Murase; F Franks
Journal:  Biophys Chem       Date:  1989-11       Impact factor: 2.352

5.  Effect of initial buffer composition on pH changes during far-from-equilibrium freezing of sodium phosphate buffer solutions.

Authors:  G Gómez; M J Pikal; N Rodríguez-Hornedo
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

6.  Solid-state characteristics of amorphous sodium indomethacin relative to its free acid.

Authors:  P Tong; G Zografi
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

7.  Polymers protect lactate dehydrogenase during freeze-drying by inhibiting dissociation in the frozen state.

Authors:  T J Anchordoquy; J F Carpenter
Journal:  Arch Biochem Biophys       Date:  1996-08-15       Impact factor: 4.013

8.  Characterization of frozen aqueous solutions by low temperature X-ray powder diffractometry.

Authors:  R K Cavatur; R Suryanarayanan
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

9.  Electrolyte-induced changes in glass transition temperatures of freeze-concentrated solutes.

Authors:  L M Her; M Deras; S L Nail
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

10.  Glycine crystallization during freezing: the effects of salt form, pH, and ionic strength.

Authors:  M J Akers; N Milton; S R Byrn; S L Nail
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

View more
  8 in total

1.  The effect of crystallizing and non-crystallizing cosolutes on succinate buffer crystallization and the consequent pH shift in frozen solutions.

Authors:  Prakash Sundaramurthi; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2010-10-07       Impact factor: 4.200

Review 2.  Design of freeze-drying processes for pharmaceuticals: practical advice.

Authors:  Xiaolin Tang; Michael J Pikal
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

3.  The effect of stabilizers and denaturants on the cold denaturation temperatures of proteins and implications for freeze-drying.

Authors:  Xiaolin Charlie Tang; Michael J Pikal
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

Review 4.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

5.  Influence of formulation factors on the preparation of zein nanoparticles.

Authors:  Satheesh Podaralla; Omathanu Perumal
Journal:  AAPS PharmSciTech       Date:  2012-06-26       Impact factor: 3.246

Review 6.  Citric Acid: A Multifunctional Pharmaceutical Excipient.

Authors:  Maria Lambros; Thac Henry Tran; Qinqin Fei; Mike Nicolaou
Journal:  Pharmaceutics       Date:  2022-04-30       Impact factor: 6.525

7.  Investigations into the stabilization of drugs by sugar glasses: III. The influence of various high-pH buffers.

Authors:  Jonas H C Eriksson; Wouter L J Hinrichs; Gerhardus J de Jong; Govert W Somsen; Henderik W Frijlink
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

8.  Impact of Buffer, Protein Concentration and Sucrose Addition on the Aggregation and Particle Formation during Freezing and Thawing.

Authors:  Astrid Hauptmann; Katja Podgoršek; Drago Kuzman; Stanko Srčič; Georg Hoelzl; Thomas Loerting
Journal:  Pharm Res       Date:  2018-03-19       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.